CFO Swyt Greg sold $456K in ICHR shares at $66.81, reducing his stake by 11.4% in his second sale this month. This trade continues a recent bearish cluster of insider sales, though the stock remains 62.7% above its 90-day low, suggesting the sales may follow a significant price recovery.

Where it could go — Analyst mean target not provided; bear case if stock breaks the recent low of $62.17.

Philip Ryan Barros Sr., CEO of ICHR, sold 13,705 shares at ~$70.19 for $962K; 1,403 of them came from a same-day option exercise at $21.76. The remaining 12,302 shares came from existing holdings, leaving him with 165,078 directly held shares.

Where it could go — Modest reduction of his existing holdings — about 90 percent of the sale drew from existing stock, a meaningful trim of direct position despite the small option component.

Director Laura Black sold $1.5M worth of ICHR shares at $75.02, reducing her stake by 49% in her first-ever transaction. This follows multiple recent director sales at ICHR, creating a pattern of insider distribution near the stock's 90-day high despite strong analyst consensus.

Where it could go — Analyst mean target unavailable; bear case if stock breaks below recent support at $56.60.

CFO Swyt Greg sold $1.4M of ICHR at $70.42, reducing his stake by 24% while the stock traded 9.7% below its 90-day high after an 83% rally from lows. This first-ever trade by the CFO suggests profit-taking near resistance despite strong analyst consensus, creating a bearish divergence between insider action and Wall Street sentiment. Breaks $65 → $58; holds above $72 → $78 retest.

Where it could go — Broad base rate 0% positive at 90d; bear breaks $65, bull holds $72.

Director Titinger Jorge sold $257K in ICHR, reducing his stake by 24.5% from a price 17.7% below the 90-day high. This first-time sale is a notable negative signal from a director, but its bearishness is tempered by the stock's position well above its recent low and a lack of corroborating insider sales.

Where it could go — Analyst mean target not provided; bear case if stock breaks the 30-day low of $56.60.

Director Marc Haugen executed Form 4 Code S sale of $404K in ICHR shares, reducing his stake by 33%. This marks his second open-market sale in five days, following a $432K sale on May 8th. The sale occurred at $75.63, just 3.0% below the 90-day high, while analyst consensus remains Strong Buy with 11 buy ratings.

Where it could go — No historical pattern data exists for similar ICHR director sales; bear case requires the stock to break below the 30-day low of $56.60 to confirm selling pressure.

Director Haugen Marc sold 6,000 shares of ICHR via open-market transaction (Code S) at $71.96, reducing his holdings by 23.0%. This is his first recorded Form 4 filing, with no prior open-market purchase (Code P) or sale history. The sale occurred 4.5% below the 90-day high of $75.35, amid a STRONG BUY analyst consensus.

Where it could go — In the absence of historical return data for similar ICHR insider transactions, the mean analyst target implies 18.2% upside from $71.96; bear case requires the $32.03 low to break.

Director Haugen Marc sold 6,000 shares of ICHR via open-market transaction (Code S) at $71.96, reducing his holdings by 23.0%. This is his first recorded Form 4 filing, with no prior open-market purchase (Code P) or sale history. The sale occurred 4.5% below the 90-day high of $75.35, amid a STRONG BUY analyst consensus.

Where it could go — In the absence of historical return data for similar ICHR insider transactions, the mean analyst target implies 18.2% upside from $71.96; bear case requires the $32.03 low to break.